The occurrence of stroke induces a series of complex responses, which in turn leads to a set of complex pathological changes, and different types of stroke cause different cascades of responses. Although research related to the injury mechanisms of stroke has been conducted for decades, many mysteries remain unanswered. To accelerate the understanding of stroke, Ace Therapeutics offers a comprehensive service to explore the pathogenic mechanisms of stroke injury.
Ischemic stroke is the most common form of stroke. The center of the brain region with reduced blood flow after ischemia is the ischemic core, and within this region, neurons undergo irreversible death within minutes. Surrounding the ischemic core is the penumbra, an area that keeps neurons quiescent because of a collateral blood supply. If blood flow to the penumbra is not restored, these neurons remain dead eventually and become part of the ischemic infarct. Ischemic stroke activates a series of harmful signaling cascades, including excitotoxicity, oxidative stress, neuroinflammation, and blood-brain barrier breakdown, which ultimately lead to neuronal death.
Fig. 1 Schematic representation of ischemia induced signaling cascade in the brain (Paul, et al., 2021)
The occurrence of a hemorrhagic stroke induces a cascade leading to primary and secondary brain injury.
Fig. 2 Schematic representation of hemorrhagic induced signaling cascade in the brain
Ace Therapeutics is a biological company specializing in pre-clinical CRO services for stroke. We have professional scientists, the latest technology, and advanced equipment. Our company provides stroke-related services such as basic research and stroke therapy development. We work with you to gain insight into the pathogenesis of stroke and develop more effective treatments. Feel free to contact us with any stroke-related questions.